🟢 90/100

This product looks safe

  • Fish Oil: 4383mg is 1.5× the Tolerable Upper Intake Level (3000mg)
  • 25% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Fish Oil: 4383mg is 1.5× the Tolerable Upper Intake Level (3000mg)

Label Data

1 tsp Serving Size
30 Servings
Fat/Fatty Acid Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
45 {Calories}
Total Fat
5 Gram(s) (8% DV)
Cholesterol
90 mg (30% DV)
4383 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.5× (UL: 3000 mg) 📚 388 studies (Tier A: 18, B: 204)
This product: 4383mg UL 3000mg

Other Ingredients

Orange Oil Mixed Tocopherols

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Children (All)

Product Information

📋 Directions for Use

Recommended Dose: Adults and Children (1 year and older): Take one teaspoon daily with a meal or as recommended by your healthcare practitioner.

⚠️ Warnings & Precautions

Quality Assurance: Vacuum-sealed for your protection and for product freshness. Do not use if outer seal is missing or broken.

🧪 Formulation Notes

Guaranteed to contain no added wheat, starch, yeast, gluten, corn, sodium, sugar, artificial coloring or flavoring, antimicrobial preservatives or dairy products.

Additional Information

Refrigerate after opening.

446

Seroyal

QUALITY TESTED Natural Triglyceride Form

446

Product Details

UPC / SKU 883196 11481
DSLD Entry Date 2016-02-23
Product Type Fat/Fatty Acid
Form Liquid
DSLD ID 56227
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →